🔎 Trials Near Me

Почетна › Ulcerativni kolitis › Њујорк

Kliničke studije za Ulcerativni kolitis u državi Њујорк

28 studija za Ulcerativni kolitis traži učesnike na lokacijama u državi Њујорк.

Gradovi u državi Њујорк

Zvanični tekst studije (na engleskom)

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

  • Site US-002, Albany
  • Site US-016, Rochester
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 12. 11. 2026. · NCT07845487

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • NYU Langone Hospital - Long Island, Mineola
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • и још 1
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT03816345

A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

  • Columbia University Medical Center, New York
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 12. 11. 2026. · NCT06636656

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

  • New York Gastroenterology Associates ( Site 0253), New York
Тражи се учесникФаза 3
Сви узрасти · Оба пола · Ажурирано 10. 11. 2026. · NCT06651281

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

  • Stony Brook University, Stony Brook
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 4. 11. 2026. · NCT07415044

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Icahn School of Medicine at Mount Sinai, New York
  • New York Gastroenterology Associates, New York
  • Care Access - Yonkers, Yonkers
Тражи се учесникФаза 3
Узраст од 18 до 70 · Оба пола · Ажурирано 4. 11. 2026. · NCT06937086

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

  • Digestive Disease Medicine of Central New York, Utica
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 4. 11. 2026. · NCT07186101

Safety, Dosage, and Microbiome Engraftment Study of MGT-006 for Ulcerative Colitis (ROOT Study)

  • NYU Langone Health, New York
Тражи се учесникФаза 1/2
Узраст од 18 до 75 · Оба пола · Ажурирано 3. 11. 2026. · NCT07913347

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

  • New York Gastroenterology Associates, New York
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07577856

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

  • Xencor Investigative Site, Albany
  • Xencor Investigative Site, Rochester
Тражи се учесникФаза 1/2Здраве особе су добродошле
Узраст од 18 до 75 · Оба пола · Ажурирано 30. 10. 2026. · NCT06619990

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

  • Westchester Putnam Gastroenterology PC, Carmel
  • Five Towns Gastroenterology, Cedarhurst
  • IMIDeology, Elmhurst
  • и још 5
Тражи се учесникФаза 4
Узраст од 18 до 80 · Оба пола · Ажурирано 28. 10. 2026. · NCT06581328

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

  • Intercity Gastroenterology, Fresh Meadows
  • University of Rochester - PARENT, Rochester
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 27. 10. 2026. · NCT06979336

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

  • New York Gastroenterology Associates - Upper East Side /ID# 281767, New York
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 27. 10. 2026. · NCT07697456

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

  • Site 037, New York
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 27. 10. 2026. · NCT07012395

A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis

  • Fink Children's Ambulatory Care Center, New York
  • Kimmel Pavilion - NYU Langone, New York
  • NYU Grossman School of Medicine, New York
  • и још 4
Тражи се учесникФаза 2
Узраст од 2 до 11 · Оба пола · Ажурирано 26. 10. 2026. · NCT07470879

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

  • NYU Langone Health, New York
  • Lenox Hill Hospital, Northwell Health, New York
Тражи се учесникОпсервациона студија
Узраст од 18 до 64 · Оба пола · Ажурирано 26. 10. 2026. · NCT06398626

Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)

  • State University of New York Upstate Medical University, Syracuse
Тражи се учесник
Узраст од 18 до 85 · Оба пола · Ажурирано 23. 10. 2026. · NCT05987852

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

  • MedTraits NY - Site Number: 8400045, Maspeth
  • Manhattan Clinical Research, LLC - Site Number: 8400069, New York
  • NYU Langone Health - Site Number: 8400091, New York
  • и још 4
Тражи се учесникФаза 3
Узраст од 16 до 80 · Оба пола · Ажурирано 23. 10. 2026. · NCT07184996

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

  • Columbia University Medical Center, New York
Тражи се учесникФаза 2/3
Узраст од 2 до 17 · Оба пола · Ажурирано 20. 10. 2026. · NCT05076175

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

  • MedTraits NY - Site Number: 8400045, Maspeth
  • NYU Langone Health-Site Number: 8400091, New York
  • Weill Cornell Medicine - NewYork-Presbyterian Hospital - Site Number: 8400040, New York
  • и још 2
Тражи се учесникФаза 3
Узраст од 16 до 80 · Оба пола · Ажурирано 16. 10. 2026. · NCT07185009

Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

  • NYU Langone Health, New York
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06750731

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  • New York Presbyterian Hospital, New York
Тражи се учесникФаза 3
Узраст од 2 до 17 · Оба пола · Ажурирано 9. 10. 2026. · NCT06405087

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

  • Icahn School of Medicine at Mount Sinai, New York
Тражи се учесникФаза 3
Узраст од 2 до 19 · Оба пола · Ажурирано 7. 10. 2026. · NCT04844606

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

  • Saratoga Schenectady Gastroenterology Associates, Burnt Hills
  • NYU Langone Health, New York
  • Cornell University, New York
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 7. 8. 2026. · NCT05230173

BOOM-IBD2 Pivotal Clinical Trial

  • Northwell Health North Shore University Hospital, Manhasset
  • Columbia University Irving Medical Center/New York Presbyterian Hospital, New York
Тражи се учесник
Узраст од 18 до 85 · Оба пола · Ажурирано 6. 8. 2026. · NCT06571669

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

  • New York University, New York
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 5. 8. 2026. · NCT07237516

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

  • Mirador Therapeutics Selected Site, New York
  • Mirador Therapeutics Selected Site, Rochester
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 12. 3. 2026. · NCT07113522

Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis

  • Bausch Health Site 006, The Bronx
Тражи се учесникФаза 4
Узраст од 5 до 17 · Оба пола · Ажурирано 16. 9. 2025. · NCT04314375

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.